pomalidomide has been researched along with epz-6438 in 1 studies
Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (epz-6438) | Trials (epz-6438) | Recent Studies (post-2010) (epz-6438) |
---|---|---|---|---|---|
623 | 121 | 552 | 113 | 8 | 110 |
Protein | Taxonomy | pomalidomide (IC50) | epz-6438 (IC50) |
---|---|---|---|
[Histone H3]-lysine | Rattus norvegicus (Norway rat) | 0.004 | |
Polycomb protein EED | Homo sapiens (human) | 0.0153 | |
Histone-binding protein RBBP4 | Homo sapiens (human) | 0.004 | |
Polycomb protein SUZ12 | Homo sapiens (human) | 0.004 | |
Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | 0.0364 | |
Zinc finger protein AEBP2 | Homo sapiens (human) | 0.004 | |
Histone-lysine N-methyltransferase EZH1 | Homo sapiens (human) | 0.004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asmar, F; Christensen, J; Dimopoulos, K; Fibiger Munch-Petersen, H; Gimsing, P; Grønbaek, K; Hermansen, NEU; Liang, G; O'Connel, C; Sjö, L; Sommer Kristensen, L; Søgaard Helbo, A | 1 |
1 other study(ies) available for pomalidomide and epz-6438
Article | Year |
---|---|
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner.
Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Benzamides; Biphenyl Compounds; Cell Line, Tumor; Chromatin; DNA Methylation; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Gene Expression; Gene Expression Profiling; Humans; Lenalidomide; Morpholines; Multiple Myeloma; Peptide Hydrolases; Pyridones; Thalidomide; Ubiquitin-Protein Ligases | 2018 |